VIR Snapshot
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.
Market Capitalization$3,224,679,000
Price to Sales1.39
Earnings per Share$8.9900
PE Ratio2.709
Most Recent Close$24.1400
52 Week High$58
52 Week Low$18.21
50-Day Moving Average$22.86
200-Day Moving Average$34.78
All data are from Alpha Vantage as of today. For more infomation on VIR see Stock Dividend, Valuation, Price and Financial Data for Investors